Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells
Circulation · 2024
DOI: 10.1161/circulationaha.123.065143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Ziwen Cai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (Z.C…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cell Differentiation, Heart Valves. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: A main obstacle in current valvular heart disease research is the lack of high-quality homogeneous functional heart valve cells. Human induced pluripotent stem cells (hiPSCs)-derived heart valve cells may help with this dilemma. However, there are no well-established protocols to induce hiPSCs to differentiate into functional heart valve cells, and the networks that mediate the differentiation have not been fully elucidated. METHODS: To generate heart valve cells from hiPSCs, we sequentially activated the Wnt, BMP4, VEGF (vascular endothelial growth factor), and NFATc1 signaling pathways using CHIR-99021, BMP4, VEGF-165, and forskolin, respectively. The transcriptional and functional similarity of hiPSC-derived heart valve cells compared with primary heart valve cells were characterized. Longitudinal single-cell RNA sequencing was used to uncover the trajectory, switch genes, pathways, and transcription factors of the differentiation. RESULTS: An efficient protocol was developed to induce hiPSCs to differentiate into functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells. After 6-day differentiation and CD144 magnetic bead sorting, ≈70% CD144 + cells and 30% CD144 – cells were obtained. On the basis of single-cell RNA sequencing data, the CD144 + cells and CD144 – cells were found to be highly similar to primary heart valve endothelial cells and primary heart valve interstitial cells in gene expression profile. Furthermore, CD144 + cells had the typical function of primary heart valve endothelial cells, including tube formation, uptake of low-density lipoprotein, generation of endothelial nitric oxide synthase, and response to shear stress. Meanwhile, CD144 – cells could secret collagen and matrix metalloproteinases, and differentiate into osteogenic or adipogenic lineages like primary heart valve interstitial cells. Therefore, we identified CD144 + cells and CD144 – cells as hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells, respectively. Using single-cell RNA sequencing analysis, we demonstrated that the trajectory of heart valve cell differentiation was consistent with embryonic valve development. We identified the main switch genes (NOTCH1, HEY1, and MEF2C), signaling pathways (TGF-β, Wnt, and NOTCH), and transcription factors (MSX1, SP5, and MECOM) that mediated the differentiation. Finally, we found that hiPSC-derived valve interstitial-like cells might derive from hiPSC-derived valve endothelial-like cells undergoing endocardial-mesenchymal transition. CONCLUSIONS: In summary, this is the first study to report an efficient strategy to generate functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells from hiPSCs, as well as to elucidate the differentiation trajectory and transcriptional dynamics of hiPSCs differentiated into heart valve cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (Z.C., L.X., Y.X., W.Y.Y., H.C., R.G., X.Q, J.S., W.Q., N.D.).
- Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, China (Z.C.).
- Institute of Maternal and Children Health, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji medical College, Huazhong University of Science & Technology, Hubei, China (M.Z.).
- Department of Anesthesiology, Union Hospital, Fujian Medical University, Fuzhou, China (Y.W.).
- Department of Physiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (M.Z., X.H.).
ORCID-Profile: Ziwen Cai, Yue Wang, Wai Yen Yim, Ruikang Guo, Ximiao He, Weihua Qiao, Nianguo Dong
Zitieren
APA
Cai, Z., Zhu, M., Xu, L., Wang, Y., Xu, Y., Yim, W. Y., Cao, H., Guo, R., Qiu, X., He, X., Shi, J., Qiao, W., & Dong, N. (2024). Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells. Circulation. https://doi.org/10.1161/circulationaha.123.065143
Vancouver
Cai Z, Zhu M, Xu L, Wang Y, Xu Y, Yim WY, et al. Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells. Circulation. 2024. doi:10.1161/circulationaha.123.065143
BibTeX
@article{Cai2024,
author = {Cai, Ziwen and Zhu, Miaomiao and Xu, Li and Wang, Yue and Xu, Yin and Yim, Wai Yen and Cao, Hong and Guo, Ruikang and Qiu, Xiang and He, Ximiao and Shi, Jiawei and Qiao, Weihua and Dong, Nianguo},
title = {Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.065143}
}
EUVIMED